Live tape
Top 8, mentions 7d15,265NVDA6,540 mentions▲ +0.04GOOGL1,864 mentions▲ +0.04SPY1,671 mentions▲ +0.05QQQ1,446 mentions▲ +0.05SPCX1,139 mentions▲ +0.06AMD950 mentions▲ +0.08MSFT842 mentions▲ +0.03CRWV813 mentions▲ +0.07

Equity · Healthcare

CMPX

NASDAQ

Compass Therapeutics (CMPX)

0.8394 USD +1.00% vs prior close Nov 10, 2026
Compass Therapeutics, Inc. price graph
63 sessions
3 0 13 Aug 10 Nov

The line runs 2.29 USD on 13 August through 0.8394 USD on 10 November, on a scale from 0 to 3. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView
Market cap
151.2M USD
Revenue, year to Dec 2025
0 USD
EPS, diluted, year to Dec 2025
−0.42 USD
Avg volume
153.8K

as of Nov 10, 2026

Have Compass Therapeutics (CMPX) insiders bought or sold shares recently?

In the 90 days to 11 Nov 2026, Compass Therapeutics insiders reported 2 open-market purchases and no sales (SEC Form 4).

Form 4, 90 days to 11 Nov 2026, newest reported trade 1 Oct 2026

2buys
0sells
$21Knet bought
0other filings
Have Compass Therapeutics (CMPX) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
01 Oct 2026Lerner NeilChief Accounting OfficerBuy20,00018K USD
24 Sep 2026Lerner NeilChief Accounting OfficerBuy2,5003K USD
Bought2 open-market purchases22,500$21K

Which funds hold Compass Therapeutics (CMPX)?

1 of the 45 institutional funds we track reported a Compass Therapeutics position for the quarter ended 30 Sep 2026 — a combined 2.0M USD; the latest of those filings landed 06 Nov 2026.

Form 13F

Which funds hold Compass Therapeutics (CMPX)?
FundPositionSharesValueShares q/q
Fisher Asset ManagementAdded1,945,8212.0M USD+39.8%

What has been filed or recorded for Compass Therapeutics (CMPX)?

The filings we hold for Compass Therapeutics, newest first: 6 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 14 Oct 2026. No next earnings date is announced in SEC filings yet.

What has been filed or recorded for Compass Therapeutics (CMPX)?
And
14 Oct 2026Fails to deliverShares failed to deliver11,592 shares10K USD notional · 0.006% of shares out
13 Oct 2026Fails to deliverShares failed to deliver67,396 shares63K USD notional · 0.037% of shares out
07 Oct 2026Fails to deliverShares failed to deliver59,820 shares60K USD notional · 0.033% of shares out
01 Oct 2026Fails to deliverShares failed to deliver38,898 shares40K USD notional · 0.022% of shares out
30 Sep 2026Fails to deliverShares failed to deliver3,233 shares4K USD notional · 0.002% of shares out
30 Sep 2026Quarterly earningsQ3 2026 reportedEPS −0.15 USD
30 Sep 2026FinancialsTotal assets174.5M USDat period end
30 Sep 2026FinancialsTotal equity142.6M USDat period end
29 Sep 2026Fails to deliverShares failed to deliver31,985 shares36K USD notional · 0.018% of shares out
30 Jun 2026Quarterly earningsQ2 2026 reportedEPS −0.13 USD
31 Mar 2026Quarterly earningsQ1 2026 reportedEPS −0.10 USD
31 Dec 2025Annual reportFY 2025 reportedEPS −0.42 USD
31 Dec 2025FinancialsRevenue0 USDfiscal year
31 Dec 2025FinancialsNet income−66.5M USDfiscal year
31 Dec 2025FinancialsEarnings per share basic−0.42 USDfiscal year
30 Sep 2025Quarterly earningsQ3 2025 reportedEPS −0.08 USD
30 Jun 2025Quarterly earningsQ2 2025 reportedEPS −0.14 USD
31 Mar 2025Quarterly earningsQ1 2025 reportedEPS −0.12 USD
31 Dec 2024Annual reportFY 2024 reportedEPS −0.36 USD

What do people ask about Compass Therapeutics (CMPX)?

From live data
What did Compass Therapeutics shares close at?0.8394

Compass Therapeutics closed at 0.8394 USD on 10 Nov 2026, up 1.00% on the close before. That is the end-of-day price from Finazon, not a live quote.

What is Compass Therapeutics’ market cap?151.2M

Compass Therapeutics is worth 151.2M USD by market value as of 10 Nov 2026, which is the share price times the shares on issue from its SEC filings.

What is Compass Therapeutics’ revenue?0

Compass Therapeutics reported revenue of 0 USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings

Have Compass Therapeutics insiders bought or sold shares recently?2 purchases

In the 90 days to 11 Nov 2026, Compass Therapeutics insiders reported 2 open-market purchases and no sales (SEC Form 4). See Insiders

Which funds own Compass Therapeutics?1 of 45

1 of the 45 funds we track reported a Compass Therapeutics position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported position was Fisher Asset Management. See Funds

When did Compass Therapeutics last report earnings?−0.15

Compass Therapeutics last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of −0.15 USD; no next date is announced in SEC filings yet. See Filings

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARForm 4 filings (insider transactions)
  4. SEC EDGAR13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
  7. SEC EDGARreported earnings figures and scheduled report dates
  8. SEC EDGARValuation computed from SEC EDGAR filings